These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23972339)

  • 21. Impact of margin status at 37 months after robot assisted radical prostatectomy.
    Warner JN; Nunez RN; Mmeje CO; Colby TV; Ferrigni RG; Humphreys MR; Andrews PE; Castle EP
    Can J Urol; 2011 Dec; 18(6):6043-9. PubMed ID: 22166333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised controlled trial comparing laparoscopic and robot-assisted radical prostatectomy.
    Porpiglia F; Morra I; Lucci Chiarissi M; Manfredi M; Mele F; Grande S; Ragni F; Poggio M; Fiori C
    Eur Urol; 2013 Apr; 63(4):606-14. PubMed ID: 22840353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
    Ficarra V; Borghesi M; Suardi N; De Naeyer G; Novara G; Schatteman P; De Groote R; Carpentier P; Mottrie A
    BJU Int; 2013 Aug; 112(3):338-45. PubMed ID: 23470027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy.
    Fujimura T; Fukuhara H; Taguchi S; Yamada Y; Sugihara T; Nakagawa T; Niimi A; Kume H; Igawa Y; Homma Y
    BMC Cancer; 2017 Jun; 17(1):454. PubMed ID: 28662644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy.
    Loeb S; Roehl KA; Viprakasit DP; Catalona WJ
    Eur Urol; 2008 Jul; 54(1):88-94. PubMed ID: 18400368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
    Meijer D; van Leeuwen PJ; Eppinga WSC; Vanneste BGL; Meijnen P; Daniels LA; van den Bergh RCN; Lont AP; Bodar YJL; Ettema RH; de Bie KCC; Oudshoorn FHK; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Heymans MW; Oprea-Lager DE; Schaake EE; Vis AN
    Eur Urol Open Sci; 2024 Mar; 61():37-43. PubMed ID: 38384437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
    Suardi N; Porter CR; Reuther AM; Walz J; Kodama K; Gibbons RP; Correa R; Montorsi F; Graefen M; Huland H; Klein EA; Karakiewicz PI
    Cancer; 2008 Mar; 112(6):1254-63. PubMed ID: 18286530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage robot assisted radical prostatectomy: A propensity matched study of perioperative, oncological and functional outcomes.
    Bates AS; Samavedi S; Kumar A; Mouraviev V; Rocco B; Coelho R; Palmer K; Patel VR
    Eur J Surg Oncol; 2015 Nov; 41(11):1540-6. PubMed ID: 26163049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram.
    Meijer HJ; Debats OA; Roach M; Span PN; Witjes JA; Kaanders JH; van Lin EN; Barentsz JO
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1186-91. PubMed ID: 22520482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
    Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
    Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G
    Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.
    Malik RD; Goldberg JD; Hochman T; Lepor H
    Eur Urol; 2011 Sep; 60(3):548-53. PubMed ID: 21652145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical and oncological outcomes in patients with a preoperative PSA value <4 ng/ml undergoing robot-assisted radical prostatectomy.
    Zugor V; Labanaris AP; Bauer RM; Witt JH
    Anticancer Res; 2012 May; 32(5):2079-83. PubMed ID: 22593492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.
    Zugor V; Witt JH; Heidenreich A; Porres D; Labanaris AP
    Anticancer Res; 2012 May; 32(5):2091-5. PubMed ID: 22593494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.
    Draulans C; Van Damme N; Isebaert S; Everaerts W; Silversmit G; Joniau S; De Meerleer G; Van Eycken E; Haustermans K;
    Acta Oncol; 2020 Aug; 59(8):904-910. PubMed ID: 32723224
    [No Abstract]   [Full Text] [Related]  

  • 36. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques.
    Krambeck AE; DiMarco DS; Rangel LJ; Bergstralh EJ; Myers RP; Blute ML; Gettman MT
    BJU Int; 2009 Feb; 103(4):448-53. PubMed ID: 18778350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of urinary incontinence, voiding symptoms and quality of life after open and robot-assisted radical prostatectomy.
    Geraerts I; Van Poppel H; Devoogdt N; Van Cleynenbreugel B; Joniau S; Van Kampen M
    BJU Int; 2013 Nov; 112(7):936-43. PubMed ID: 23937206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robot-assisted radical prostatectomy for the treatment of radiation-resistant prostate cancer: surgical, oncological and short-term functional outcomes.
    Zugor V; Labanaris AP; Porres D; Heidenreich A; Witt JH
    Urol Int; 2014; 92(1):20-6. PubMed ID: 24008772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological confirmation of nerve-sparing types performed during robot-assisted radical prostatectomy (RARP).
    Ko WJ; Hruby GW; Turk AT; Landman J; Badani KK
    BJU Int; 2013 Mar; 111(3):451-8. PubMed ID: 22900712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.